Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| CytoSorbents Corporation | CTSO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.8321 | 03:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.8321 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.782 - 4.29 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.8321 | USD |
CytoSorbents Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 36.88M | 44.44M | - | 36.35M | -28.51M | -0.64 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
CytoSorbents News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/13/2024 | 06:00 | GlobeNewswire Inc. | CytoSorbents Announces the Launch and Immediate Availability.. |
| 6/10/2024 | 15:31 | Edgar (US Regulatory) | Form 8-K - Current report |
| 6/05/2024 | 06:00 | GlobeNewswire Inc. | CytoSorbents to Host its 2024 Virtual Annual Stockholders.. |
| 5/22/2024 | 15:35 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/09/2024 | 16:23 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/09/2024 | 15:17 | GlobeNewswire Inc. | CytoSorbents Reports First Quarter 2024 Results |
| 5/09/2024 | 15:14 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/06/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/02/2024 | 06:00 | GlobeNewswire Inc. | CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor.. |
| 4/26/2024 | 06:00 | GlobeNewswire Inc. | CytoSorbents to Report First Quarter 2024 Operating and.. |
| 4/17/2024 | 06:00 | GlobeNewswire Inc. | STAR-T Pivotal Trial Results to Be Featured as a.. |
| 3/06/2024 | 06:00 | GlobeNewswire Inc. | CytoSorbents to Report Fiscal 2023 Operating and Financial.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CTSO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.88 | 0.90 | 0.832 | 0.8611585 | 87,903 | -0.0479 | -5.44% |
| 1 Month | 0.9695 | 0.99 | 0.832 | 0.8916557 | 59,160 | -0.1374 | -14.17% |
| 3 Months | 0.92 | 1.02 | 0.782 | 0.8836174 | 90,447 | -0.0879 | -9.55% |
| 6 Months | 2.00 | 2.15 | 0.782 | 1.04 | 201,880 | -1.17 | -58.40% |
| 1 Year | 3.48 | 4.29 | 0.782 | 1.35 | 153,197 | -2.65 | -76.09% |
| 3 Years | 7.92 | 9.80 | 0.782 | 3.39 | 183,472 | -7.09 | -89.49% |
| 5 Years | 6.68 | 13.89 | 0.782 | 5.98 | 267,949 | -5.85 | -87.54% |
CytoSorbents Description
| CytoSorbents Corp is a critical care immunotherapy leader commercializing its European Union approved CytoSorb blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients in around 55 countries. The company is conducting its pivotal REFRESH 2 - AKI cardiac surgery trial, designed to support U.S. FDA approval. The company's product portfolio consists of CytoSorb, ContrastSorb, VetResQ, HemoDefend and others. The company has around 19 issued U.S. patents, multiple patents issued internationally, and a broad patent application portfolio pending. Geographically it derives substantial revenue from product sales in Germany. |
